Please assess the completion status of the following clinical trial:

Trial Title: Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Multi-system blunt trauma patients~* Ages 18 through 65 years, inclusive~* Admission to ICU~* Nasogastric or nasoenteric feeding tube in place~* Intention of primary medical team to feed the patient enterally~Exclusion Criteria:~* Expected mortality within 48 hours~* Intracranial hemorrhage~* Pregnant or breast feeding~* Patient, surrogate, or physician not committed to full support~* Refractory shock~* Unable to obtain enteral access~* Presence of partial or complete mechanical bowel obstruction, or ischemia, or infarction~* Current total parenteral nutrition (TPN) use, or intent to use TPN within 7 days~* Current gastrointestinal bleeding~* Requirement for vasopressors

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Omega-3 (Type: ACTIVE_COMPARATOR): 50 mg/kg per day of omega-3 fatty acids (DHA Omega-3, Martek Biosciences, Columbia, MD)
- Placebo (Type: PLACEBO_COMPARATOR): 50 mg/kg per day of vehicle

Based on this trial design, predict the completion outcome and termination type (if applicable).